Generation Bio (GBIO) Revenue & Revenue Breakdown
Generation Bio Revenue Highlights
Latest Revenue (Y)
$5.90M
Latest Revenue (Q)
$4.06M
Generation Bio Revenue by Period
Generation Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.90M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $36.00K | - |
Generation Bio generated $5.90M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 16400.00% compared to the same period a year ago.
Generation Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $4.06M | 41.04% |
| 2023-12-31 | $2.88M | 34.11% |
| 2023-09-30 | $2.15M | 143.86% |
| 2023-06-30 | $880.00K | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | - |
Generation Bio generated $4.06M in revenue during Q1 2024, up 41.04% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Generation Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| KRON | Kronos Bio | $6.29M | $2.69M |
| GBIO | Generation Bio | $5.90M | $4.06M |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| FIXX | Q32 Bio | $1.16M | - |
| LYEL | Lyell Immunopharma | $130.00K | $3.00K |
| CCCC | C4 Therapeutics | - | - |
| NKTX | Nkarta | - | - |
| ERAS | Erasca | - | - |
| PASG | Passage Bio | - | - |
| SANA | Sana Bio | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| EWTX | Edgewise Therapeutics | - | - |
| NUVB | Nuvation Bio | - | $1.44M |
GBIO Revenue FAQ
What is Generation Bio’s yearly revenue?
Generation Bio's yearly revenue for 2023 was $5.9M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. GBIO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Generation Bio’s quarterly revenue?
Generation Bio's quarterly revenue for Q1 2024 was $4.06M, a 41.04% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.88M, a 34.11% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). GBIO's quarterly revenue for Q3 2023 was $2.15M, a 143.86% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Generation Bio’s revenue growth rate?
Generation Bio's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.